
Qiang Yuan
Articles
-
Oct 15, 2024 |
medrxiv.org | Fang Yuan |Haofei Wang |Qiang Yuan |Ain Nur Ali
The authors have declared no competing interest.
-
Feb 9, 2024 |
pubs.rsc.org | Qiang Yuan
Y. Zhou and Q. Yuan, Chem. Commun., 2024, Accepted Manuscript , DOI: 10.1039/D4CC00030G To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page. If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
-
Jan 23, 2024 |
bmjopen.bmj.com | Qiang Yuan |Xiaoyan Wang |Li Zhou |Chuan Li
COMPLEMENTARY MEDICINEGASTROENTEROLOGYNursing CareAll types of clinical studies on chronic constipation across all elderly age groups will be included without language limitations. The use of Cochrane quality assessment tools will ensure rigorous and standardised methodology. The systematic review will rely solely on published data, potentially excluding relevant although unpublished studies.
-
Oct 22, 2023 |
onlinelibrary.wiley.com | Zhifu Wang |Qiang Yuan |Fang Yuan |Danyi Zheng
1 Introduction Ischemic stroke results from a sudden reduction in cerebral blood flow. It has afflicted ∼25% people over their lifetime, accounting for almost 5% of all disability-adjusted life-years and 10% of all deaths worldwide.[1] Current treatment is reperfusion during the acute stage of stroke. There is no effective treatment beyond the acute stage. There is, therefore, an unmet need to develop a treatment for ischemic stroke.
-
Feb 1, 2023 |
pubs.rsc.org | Qiang Yuan |Xun Wang
Cr-doped Pd metallene nanoribbon superstructures for oxygen reduction reaction and formic acid oxidation Shanshan Chen, Qiang Yuan and Xun Wang Abstract Metallene is receiving continuous attention because of its unique properties in electrocatalysis. Herein, we report a new class of three-dimensional (3D) Cr-doped Pd metallene nanoribbon (PdCr MNR) assembly.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →